A COST UTILITY ANALYSIS OF ANTI-TNF AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

被引：0
|
作者：
Adams, R. C. [1 ]
Walsh, C. [2 ]
Schmitz, S. [2 ]
Barton, P. [3 ]
Barry, M. [1 ]
机构：
[1] Natl Ctr Pharmacoecon, Dublin, Ireland
[2] Trinity Coll Dublin, Dublin, Ireland
[3] Univ Birmingham, Birmingham, W Midlands, England
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.437
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A311 / A312
页数：2
相关论文
共 50 条
  • [1] Anti-TNF agents for rheumatoid arthritis
    Seymour, HE
    Worsley, A
    Smith, JM
    Thomas, SHL
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (03) : 201 - 208
  • [2] Immunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritis
    Mok, Chi Chiu
    Tsai, Wen Chan
    Chen, Der Yuan
    Wei, James Cheng Chung
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (02) : 201 - 211
  • [3] Anti-TNF Treatment in Rheumatoid Arthritis
    Geiler, Janina
    Buch, Maya
    McDermott, Michael F.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (29) : 3141 - 3154
  • [4] UTILITY-COST ANALYSIS OF RITUXIMAB AFTER FAILURE OF ANTI-TNF IN RHEUMATOID ARTHRITIS FOR COLOMBIA
    Romero, M.
    Latorre, M.
    Alvarado, C.
    Karpf, E.
    Alvis, N.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A536 - A536
  • [5] COST ANALYSIS OF RECENTLY APPROVED AND OLDER ANTI-TNF BIOLOGIC AGENTS USED IN RHEUMATOID ARTHRITIS
    Carter, C.
    Schmeichel-Mueller, C.
    McKenzie, R. S.
    Piech, C. T.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A123 - A123
  • [6] Rheumatoid Arthritis - Anti-TNF
    Chaabo, Khaldoun
    Kirkham, Bruce
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 27 (02) : 180 - 184
  • [7] Complex genetic relationship of the TNF locus with response to anti-TNF agents in the treatment of rheumatoid arthritis
    Maxwell, James
    Potter, Catherine
    HyrichBrAGGSS, Kimme, III
    Barton, Anne
    Worthington, Jane
    Isaacs, John
    Morgan, Ann
    Wilson, Anthony G.
    [J]. RHEUMATOLOGY, 2008, 47 : II12 - II12
  • [8] Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model
    Dos Santos, Jessica Barreto Ribeiro
    da Silva, Michael Ruberson Ribeiro
    Almeida, Alessandra Maciel
    Acurcio, Francisco De Assis
    Alvares-Teodoro, Juliana
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (05) : 1011 - 1016
  • [9] Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
    Martin J. Bergman
    Alan J. Kivitz
    Dimitrios A. Pappas
    Joel M. Kremer
    Lixia Zhang
    Anna Jeter
    Johanna B. Withers
    [J]. Rheumatology and Therapy, 2020, 7 : 775 - 792
  • [10] Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
    Bergman, Martin J.
    Kivitz, Alan J.
    Pappas, Dimitrios A.
    Kremer, Joel M.
    Zhang, Lixia
    Jeter, Anna
    Withers, Johanna B.
    [J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 775 - 792
12345